A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer
Biomedicines 2018, 6(4), 104; https://doi.org/10.3390/biomedicines6040104
Christopher J. LaRocca and Susanne G. Warner
Department of Surgery, City of Hope National Medical Center, Duarte, CA 91010, USA
(This article belongs to the Special Issue Viruses in Cancer and Therapy)
Cancer - Pancreatic category listing has 58 items along with related searches
- Pancreatic Cancer Survival 40 percent more likely if had adequate vitamin D (30 ng) – June 2016
- Pancreatic cancer 55 percent less likely if optimal vitamin D (vs low) – Nov 2017
- Pancreatic cancer risk of death reduced 19 percent by Vitamin D – meta-analysis June 2017
- Pancreatic Cancer stabilized by a woman taking 50,000 IU of vitamin D daily - 2016
Omega-3 helps
- Pancreatic Cancer is increasing – Vitamin D and Omega-3 should reduce the risk
- Severe acute pancreatitis treated in 11 ways by Omega-3 in just 7 days – RCT April 2018
- Omega-3 should help Pancreatic Cancer in 5 ways – June 2017
Other supplements of interest
- Pancreatic Cancer risk increased 24 percent for every 100 mg less of Magnesium intake – Dec 2015
- Pancreatic cancer prevention and treatment by alternates – Vitamin D, Vitamin C, Curcumin, etc – July 2018
Download the PDF from VitaminDWiki
Oncolytic viruses have emerged as a novel class of anti-cancer therapeutics with one virus already receiving United States Food and Drug Administration (FDA) approval (talimogene laherparepvec) and many others undergoing testing in clinical trials. These viruses have direct lytic effects on tumor cells as well as immunomodulatory functions to increase inflammatory cell infiltrates in the tumor microenvironment. Despite all of the advances in cancer care, pancreatic cancer remains a highly lethal malignancy. One of the main barriers to successful systemic treatment of the disease is the fibrotic tumor stroma, as the unique extracellular matrix creates an environment that promotes tumor growth and is resistant to chemotherapy and other anti-cancer agents. The pleiotropic effects of Vitamin D have been widely studied, but recent research has now demonstrated it to be an effective agent in modulating pancreatic cancer stroma to facilitate the enhanced delivery of cytotoxic chemotherapy and immunogenicity in response to treatment. This review will explore the combination of Vitamin D with oncolytic viruses and how this novel application of Vitamin D’s ability to modulate pancreatic tumor stroma may result in a potential mechanism for increasing the efficacy of oncolytic virotherapy in pancreatic cancer.
Pancreatic Cancer trials using Vitamin D and viral therapy – Nov 2018
5614 visitors, last modified 21 Sep, 2019,
Printer Friendly
Follow this page for updates
This page is in the following categories (# of items in each category)
- Pancreatic Cancer Survival 40 percent more likely if had adequate vitamin D (30 ng) – June 2016
- Pancreatic cancer 55 percent less likely if optimal vitamin D (vs low) – Nov 2017
- Pancreatic cancer risk of death reduced 19 percent by Vitamin D – meta-analysis June 2017
- Pancreatic Cancer stabilized by a woman taking 50,000 IU of vitamin D daily - 2016
Omega-3 helps
- Pancreatic Cancer is increasing – Vitamin D and Omega-3 should reduce the risk
- Severe acute pancreatitis treated in 11 ways by Omega-3 in just 7 days – RCT April 2018
- Omega-3 should help Pancreatic Cancer in 5 ways – June 2017
Other supplements of interest
- Pancreatic Cancer risk increased 24 percent for every 100 mg less of Magnesium intake – Dec 2015
- Pancreatic cancer prevention and treatment by alternates – Vitamin D, Vitamin C, Curcumin, etc – July 2018
Download the PDF from VitaminDWiki
Oncolytic viruses have emerged as a novel class of anti-cancer therapeutics with one virus already receiving United States Food and Drug Administration (FDA) approval (talimogene laherparepvec) and many others undergoing testing in clinical trials. These viruses have direct lytic effects on tumor cells as well as immunomodulatory functions to increase inflammatory cell infiltrates in the tumor microenvironment. Despite all of the advances in cancer care, pancreatic cancer remains a highly lethal malignancy. One of the main barriers to successful systemic treatment of the disease is the fibrotic tumor stroma, as the unique extracellular matrix creates an environment that promotes tumor growth and is resistant to chemotherapy and other anti-cancer agents. The pleiotropic effects of Vitamin D have been widely studied, but recent research has now demonstrated it to be an effective agent in modulating pancreatic cancer stroma to facilitate the enhanced delivery of cytotoxic chemotherapy and immunogenicity in response to treatment. This review will explore the combination of Vitamin D with oncolytic viruses and how this novel application of Vitamin D’s ability to modulate pancreatic tumor stroma may result in a potential mechanism for increasing the efficacy of oncolytic virotherapy in pancreatic cancer.
| 5614 visitors, last modified 21 Sep, 2019, |